Aetna Says It'll Sell Its Medicare Drug Business As It Seeks Approval For Its $69 Billion Takeover of CVS

5 years ago
Health insurer Aetna said Thursday it would sell its Medicare prescription drug plan business. The company will sell to WellCare Health Plans. Aetna seeks U.S. antitrust approval for a planned acquisition by CVS Health Corp.

Business Insider says the $69 billion deal is being reviewed by the U.S. Department of Justice. If approved it would be the second largest healthcare deal this year.

Recommended